The Market of “Global
Intra-Uterine Contraceptive Devices Market” is expected to reach USD
4,851.2 million by 2024 from USD 3,684.1 million in 2016, at a CAGR of 3.5% in
the forecast period 2017 to 2024. The new market report contains data for
historic years 2015, the base year of calculation is 2016 and the forecast
period is 2017 to 2024.
Intra-Uterine Contraceptive Devices
Market Categories: Segmentation
Global Intra-Uterine
Contraceptive Devices Market, By Product Type (Hormonal IUCD, Copper IUCD),
End-User (Hospitals, Gynaecology Clinics, Community Healthcare), Geography
(North America, Europe, Asia-Pacific, South America, Middle East and Africa)
For a Free Sample Visit @ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-intra-uterine-contraceptive-devices-market
Global Intra-Uterine Contraceptive
Devices Market: Market Drivers
Some of the major factors
driving the market for Intra-Uterine Contraceptive Devices (IUCD), such as
growing awareness of contraceptive, increased rate of unplanned pregnancies,
rising number of initiatives undertaken by the private firms, technological
advancements and favourable insurance for IUCD’s.
Increased Rate of Unplanned
Pregnancies:
Adolescents most commonly
use contraceptive methods with relatively high typical use failure rates such
as condoms, withdrawal, or oral contraceptive (OC) pills. Non-use, inconsistent
use, and use of methods with high typical use failure rates are reflected in
the high rate of unintended adolescent pregnancies in the U.S.
Rising Number of Initiatives Undertaken
By the Private Firms:
The increasing number of
initiatives taken by the U.S. government has helped to limit the rising number
of unplanned pregnancies and abortions rate in the U.S. In addition, many
U.S.-based private firms also contribute towards the solutions for
pregnancy-related issues, which include maternal mortality, teenage
pregnancies, growing number of abortions, and so on, by promoting the use of
contraceptives, such as intrauterine contraceptive devices.
Favourable Insurance for IUCD’s:
The insurance policy is
propelling the IUCD market towards growth.
In Finland, national insurance covers acute but not preventive care, and
contraceptives are usually paid by the patient. In Sweden, the copper IUCDs are
available free of cost, whereas hormonal IUCDs are not. All FDA-approved
contraceptives in the U.S. are covered by insurance.
Growing Awareness of Contraceptive:
The need to avoid unwanted
pregnancies, especially among teenagers, is one of the major drivers for this
market. It has also been observed that for over half of the users also identify
non-contraceptive health benefits, such as treatment for excessive menstrual
bleeding, menstrual pain and acne, as reasons for use. This is also one of the
factors contributing to the growth of the market in Europe.
Speak
to Analyst Visit @ http://databridgemarketresearch.com/speak-to-analyst/?dbmr=global-intra-uterine-contraceptive-devices-market
Some of the major players operating in
this market are:
·
Bayer AG
·
Teva Pharmaceuticals Industries Ltd.
·
Mona Lisa N.V.
·
DKT International
·
Egemen International
·
Melbea AG, Ocon Medical Ltd.
·
Pregna International Limited
·
Medical Engineering Corporation SA
·
SMB Corporation and Meril Life Sciences Pvt. Ltd.
·
Medu Scientific Ltd
·
China RH Contraceptives Co., Ltd
·
Sanghai Jolly Medical Education Co., Ltd
·
Bernstein Leibhard LLP
·
ZheijangDaji Medical Instruments, Ltd.
·
Nimble International
·
AME Line
·
Technico
·
Cepeo
·
Contraceptivos
·
InjeflexInd
·
Com Ltd
·
Bersil
·
Amed.
The Global Intra-Uterine
Contraceptive Devices Market is highly concentrated to a
few big players and rest to local players who cater to domestic markets only.
Bayer AG dominated the IUCD devices market accounting for a highest market
share in 2016, followed by Teva Pharmaceuticals Industries Ltd., and Mona Lisa
N.V. Some of the other players in this market include DKT International, Egemen
International, Melbea AG, Ocon Medical Ltd., Pregna International Limited,
Medical Engineering Corporation SA and, SMB Corporation and Meril Life Sciences
Pvt. Ltd., Medu Scientific Ltd, China RH Contraceptives Co., Ltd, Sanghai Jolly
Medical Education Co., Ltd, Bernstein Leibhard LLP, ZheijangDaji Medical
Instruments, Ltd., Nimble International, AME Line, Technico, Cepeo,
Contraceptivos, InjeflexInd And Com Ltda, Bersil, Amed among others holds 34.0%
of the IUCDdelivery market in 2016.
BAYER
HEALTHCARE AG
Founded in 1863 and headquartered in Leverkusen, Germany,
Bayer AG is a provider of healthcare, nutrition, and high-technology materials
and services. The company has three business segments, namely, HealthCare, Crop
Science, and Material Science. The HealthCare segment offers a wide range of
products under animal health, pharmaceuticals, consumer care, and medical care.
The pharmaceutical business offers a wide range of products in the therapeutic
area of oncology, haematology, and ophthalmology, and offers products for
women’s health and cardiology therapeutic applications
Recent
Developments:
In October 2016, Bayer AG has successfully concluded the
European registration procedure to gain EUwide marketing authorization for its
new low-dose levonorgestrel-releasing intrauterine system (LNGIUS). The product
is named Kyleena and will be available in the market from 2017 January.
In September 2016, Bayer AG has successfully received FDA
approval for its new low-dose levonorgestrel releasing intrauterine system
(LNG-IUS) “Kyleena” The launch of this product in October in U.S.
Read more about the Global
Intra-Uterine Contraceptive Devices Market visit @ http://databridgemarketresearch.com/reports/global-intra-uterine-contraceptive-devices-market/
Table
of Content:
1. INTRODUCTION
2. RESEARCH
METHODOLOGY
3. MARKET OVERVIEW
4. EXECUTIVE SUMMARY
5. PREMIUM INSIGHTS
6. GLOBAL
INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET, BY PRODUCT TYPE
7. GLOBAL
INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET, BY GEOGRAPHY
8. GLOBAL
INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET: COMPETITIVE LANDSCAPE
9. GLOBAL
INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET, COMPANY PROFILES
Related
Report
Global
Prosthetic Heart Valve Market – Trends and Forecast to 2024
Global Prosthetic
Heart Valve Market, By Type (Transcatheter Heart Valve, Tissue Heart Valve, and
Mechanical Heart Valve), Geography (North America, Europe, Asia-Pacific, South
America, Middle East and Africa)– Industry Trends and Forecast to 2024
About Data Bridge Market
Research:
Data Bridge
Market Research set forth itself as an unconventional and neoteric
Market research and consulting firm with unparalleled level of resilience and
integrated approaches. We are determined to unearth the best market
opportunities and foster efficient information for your business to thrive in
the market. Data Bridge endeavors to provide appropriate solutions to the
complex business challenges and initiates an effortless decision-making
process.
Contact:
Vishal
Dixit
Data
Bridge Market Research
Tel:
+1-888-387-2818